Lexpos News

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has retrospectively adjusted the reimbursement prices of certain products dispensed in October and November 2024. Under the current price change mechanism, pharmacy owners would have to wait one (or in some cases two months) before any NHS list prices changes are applied to [...]

The post Retrospective reimbursement price adjustments appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Notification: Lansoprazole Gastro-resistant Hard Capsules 15mg (Teva UK Limited) Drug alert number: EL(25)A/06 Date issued: 11 February 2025 Teva UK Limited is reporting a minor typographical error on the carton for Lansoprazole Gastro-Resistant Hard Capsules 15mg. There are two instances where the dosage form is stated as “tablets” where it should state [...]

The post MHRA Class 4 Medicines Notification: Lansoprazole Gastro-resistant Hard Capsules 15mg (Teva UK Limited) appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets MSN/2025/006 Tier 2 medium impact Date of issue: 10th February 2025 There are supply constraints affecting quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets (see supply summary table in Supporting information). [...]

The post Medicine Supply Notification: Quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets appeared first on Community Pharmacy England.

The NHS Business Services Authority (NHSBSA) produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 58) contains some useful information and advice on: Tax credits to end on Saturday 5 April 2025 Pharmacy First – completing a supply within the Patient Group Direction (PGD) Endorsing Not Dispensed items Real [...]

The post NHSBSA ‘Hints & Tips’ – Issue 58 appeared first on Community Pharmacy England.

Drug alert number: EL (25)A/05 Date issued: 5 February 2025 CNX Therapeutics is recalling the batches listed in this notification as a precautionary measure due to a small number of packs that contain an additional tablet of Nitrofurantoin. The registered product is a capsule containing powder and two yellow tablets. Nitrofurantoin 100 mg Prolonged-Release capsules [...]

The post MHRA Class 2 Medicines recall: Nitrofurantoin 100 mg Prolonged-Release capsules (CNX Therapeutics) appeared first on Community Pharmacy England.